Top-News
Gesundheitswesen USA

PreveCeutical Medical Inc News

Aktie
WKN:  A2DU8Q ISIN:  CA74141E1043 US-Symbol:  PRVCF
0,0135 €
-0,003 €
-18,18%
14:00:42 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
535,30 Mio.
Marktkapitalisierung *
7,35 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.03.2024

PreveCeutical Medical Inc News

04.12.23 - PR Newswire
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM
PREVECEUTICAL INITIATES PREPARATION OF PROOF-​OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM PR Newswire
18.09.23 - PR Newswire
PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application
PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD ...
12.09.23 - PR Newswire
PreveCeutical Showcases Dynamic Evolution in AI Strategy
PreveCeutical Showcases Dynamic Evolution in AI Strategy PR Newswire
31.08.23 - PR Newswire
PreveCeutical Engages New to the Street for Production & Broadcasting Services
PreveCeutical Engages New to the Street for Production & Broadcasting Services PR Newswire
24.07.23 - PR Newswire
PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia
PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia PR Newswire
07.02.23 - Newsfile
PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development
Vancouver, British Columbia--(Newsfile Corp. - February 7, 2023) - PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
12.01.23 - Newsfile
PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2023) - PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
07.07.21 - Newsfile
PreveCeutical Files International Patent Application for its Dynorphin Peptides
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") , is pleased ...
15.03.21 - Newsfile
PreveCeutical Appoints Founding Director of RAS Life Science Solutions Aditya Bahl as Advisor
Vancouver, British Columbia--(Newsfile Corp. - March 15, 2021) -  PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
23.02.21 - Newsfile
Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) -  PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
02.02.21 - Newsfile
PreveCeutical Announces Completion of Pain Management Peptides Program
Vancouver, British Columbia--(Newsfile Corp. - February 2, 2021) -  PreveCeutical Medical Inc  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)   (the "Company" or "PreveCeutical")  is ...
05.01.21 - Newsfile
PreveCeutical files Provisional Patent Application for its BSV Peptide
Vancouver, British Columbia--(Newsfile Corp. - January 5, 2021) -  PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
25.11.20 - Newsfile
Successful Completion of the COVID-19 Sol-Gel Formulation Development
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2020) - PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  ("PreveCeutical") , is pleased to ...
23.11.20 - Newsfile
PreveCeutical Files Provisional Patent Application for its COVID-19 Formulation
Vancouver, British Columbia--(Newsfile Corp. - November 23, 2020) -  PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
10.11.20 - Newsfile
PreveCeutical Provides Update on Its COVID-19 Cannabinoid Sol-Gel Program
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2020) - PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  ("PreveCeutical") , is pleased to provide ...
01.10.20 - Newsfile
Veteran Johnson & Johnson Executive Dr. Ajit Shetty Joins PreveCeutical
Vancouver, British Columbia--(Newsfile Corp. - October 1, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") , is very ...
08.09.20 - Newsfile
PreveCeutical Provides Lead Pain Management Peptides Update
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2020) - PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
02.09.20 - Newsfile
PreveCeutical Announces Lead Pain Management Peptides Identified for Preclinical Evaluation
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2020) -  PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
31.08.20 - Newsfile
PreveCeutical Files an Application for a Provisional Patent for Sol-gel Cannabinoids
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2020) - PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)  (the "Company" or "PreveCeutical") , is ...
17.08.20 - Newsfile
PreveCeutical Receives AU$1,227,902 Research & Development Tax Incentive Cash Refund
Vancouver, British Columbia--(Newsfile Corp. - August 17, 2020) -  PreveCeutical Medical Inc.  (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") , is ...

Newssuche

Videos

08:55 Uhr -10,92%
Technical Trading: Rohöl Short Chance
Rohöl Short Typ: Turbo Open End WKN: VD4JF9 Hebel: 13 Laufzeit: OpenEnd Einstieg: Market ... Mehr »